Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Bionpharma – Recall of clobazam oral suspension
July 31, 2019 - The FDA enforcement report announced a class II, patient-level recall of one lot of Bionpharma’s clobazam oral suspension due to microbial contamination.
